BIOMAT Database Logo BIOMAT Database Logo

[Vitamin B12 during regular dialysis therapy]. 1987

B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014805 Vitamin B 12 A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12. Cobalamin,Cyanocobalamin,Cobalamins,Eritron,Vitamin B12,B 12, Vitamin,B12, Vitamin

Related Publications

B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Oral vitamin B12 therapy in vitamin B12 deficiency.
March 2004, The American journal of medicine,
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
[Vitamin B12 therapy].
September 1951, Munchener medizinische Wochenschrift (1950),
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Mortality during regular dialysis treatment.
November 1970, Lancet (London, England),
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Letter: Priapism during regular dialysis.
December 1974, Lancet (London, England),
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Letter: Priapism during regular dialysis.
February 1975, Lancet (London, England),
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Serum-vitamin B12 during maintenance therapy in pernicious anemia with a depot preparation of vitamin B12.
April 1966, Lancet (London, England),
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Oral vitamin B12 therapy.
December 2011, Annals of surgical oncology,
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Persistent anemia associated with reduced serum vitamin B12 levels in patients undergoing regular hemodialysis therapy.
March 1979, Clinical nephrology,
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
Diaphoretic therapy in regular dialysis patients.
July 1982, Scottish medical journal,
B Hájková, and J Erben, and P Fixa, and V Herout, and J Zahradník, and J Kubícek
[When should regular dialysis therapy begin?].
May 1988, Casopis lekaru ceskych,
Copied contents to your clipboard!